Larvol Delta - Study-to-Evaluate-the-Safety-Tolerability-and-Efficacy-of-BGE175-in-Hospitalized-Adults-With-Coronavirus-Disease-2019-COVID19-That-Are-Not-in-Respiratory-Failure

asapiprant (BGE-175) - BioAge Labs, Shionogi

http://clinicaltrials.gov/ct2/show/NCT04705597

Jun 6, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next